Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pancreatic Neoplasms × Chemoradiotherapy, Adjuvant × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 3 Esophageal Neoplasms 2 Resectable Pancreatic Cancer 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Head and Neck Neoplasms 1 Carcinoma, Squamous Cell 1

Interventions

Gemcitabine 681 130-nm albumin-bound paclitaxel 196 Fluorouracil 187 Oxaliplatin 174 Albumin-Bound Paclitaxel 153 Capecitabine 137 Leucovorin 130 Irinotecan 112 Radiotherapy 96 Taxes 86 pembrolizumab 81 Cisplatin 72 Erlotinib Hydrochloride 70 Radiosurgery 68 Nivolumab 55 Drug Therapy 55 Bevacizumab 53 Magnetic Resonance Spectroscopy 49 Cyclophosphamide 49 folfirinox 45 Docetaxel 42 Cetuximab 40 Specimen Handling 39 irinotecan sucrosofate 37 Biopsy 37 S 1 (combination) 36 Pancreaticoduodenectomy 35 Blood Specimen Collection 33 Paclitaxel 31 Surgical Procedures, Operative 30

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06427447 2025-02-04

ADJUPANC

Changhai Hospital

Phase 3 Recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡